Download Poster (424.13 KB)

Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Long-term observational joint health study in patients initiating efanesoctocog alfa: baseline data

Jonathan C. Roberts, Larissa Bornikova, Eric Grabowski, Amit Soni, Jennifer Dumont, Charlotte Sensinger, Nicole Tsao

Available materials

Poster
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Major Surgical Outcomes with Efanesoctocog Alfa: 4 Years’ Experience in the XTEND Clinical Program

Liane Khoo, Robert Klamroth, Annette von Drygalski, Sandrine Meunier, Davide Matino, Umer Khan, Elena Santagostino, Lara Mamikonian, Linda Bystrická, Graham Neill, Flora Peyvandi

Available materials

Oral Presentation
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Monitoring Joint Health in Hemophilia Patients in Spain: Updated Analysis of the JOINt US Project

María Teresa Álvarez Román, Hortensia de la Corte Rodríguez, César Ricardo Román Banks, María Victoria Aznar, Raquel Bellini, Olga Benitez Hidalgo, Rubén Berrueco Moreno, Santiago Bonanad, Francisco Cholbi, Nuria Fernández Mosteirín, Nino Haya Guaita, Francisco López Jaime, Ángel Martín Fuentes, Santiago Andrés Muñoz, Leire Ortiz Fernández, María Ángeles Peiró Garrigues, Jean Claude Perrot, María Rosario Prieto Bonilla, Manuel Rodríguez López

Available materials

Poster
Publication
  • JSH •
  • 10 October, 2025 •
  • •

One-year efficacy and safety of avatrombopag for chronic immune thrombocytopenia in Japanese adults

Hiroki Yamaguchi, Masaki Iino, Yoshiaki Tomiyama , Harumi Kamiya, Jessica Zhang, Nina Skuban

Publication
  • EHA •
  • 14 June, 2025 •
  • •

Evaluation of Efficacy and Safety of Avatrombopag in Children with Immune Thrombocytopenia based on Disease Duration: Results from the Avatrombopag Phase 3-b Pediatric Trial

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Amanda Grimes, Michele Lambert, Jessica Zhang, Brian D. Jamieson, Michael Vredenburg , Scott Kolodny

Available materials

Poster
Publication
  • EHA •
  • 14 June, 2025 •
  • •

Effectiveness and Safety of Avatrombopag for Treatment of Immune Thrombocytopenia in Older Patients and Those with Comorbidities or Prior TPO-RA Exposure: Interim Results from the Phase 4 ADOPT Study

María Eva Mingot Castellano, María Teresa Álvarez Román, María Luisa Lozano, Wolfgang Miesbach, Hafiz Qureshi, Vickie McDonald, Jessica Zhang, Viridiana Cano Garcia, Nina Skuban, Waleed Ghanima

Available materials

Poster
Publication
  • EHA •
  • 14 June, 2025 •
  • •

Efficacy and safety of avatrombopag for the treatment of pediatric immune thrombocytopenia in the open-label extension of a phase 3, randomized, double-blind, placebo-controlled trial

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Jessica Zhang, Liza Alkhori Franzén, Nina Skuban

Available materials

Poster
Sign up for alerts